Sargent Investment Group, LLC Relmada Therapeutics, Inc. Transaction History
Sargent Investment Group, LLC
- $616 Million
- Q4 2024
A detailed history of Sargent Investment Group, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Sargent Investment Group, LLC holds 11,670 shares of RLMD stock, worth $3,967. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,670
Previous 21,460
45.62%
Holding current value
$3,967
Previous $69,000
91.3%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding RLMD
# of Institutions
73Shares Held
11.4MCall Options Held
216KPut Options Held
138K-
Franklin Resources Inc San Mateo, CA1.3MShares$442,7310.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$427,2790.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.19MShares$403,3930.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA732KShares$249,0160.33% of portfolio
-
Deep Track Capital, LP Greenwich, CT675KShares$229,4430.08% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $9.73M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...